"Progestins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
| Descriptor ID |
D011372
|
| MeSH Number(s) |
D27.505.696.399.472.858
|
| Concept/Terms |
Progestins- Progestins
- Progestagens
- Progestational Hormones
- Progestogens
- Gestagen
- Progestational Compounds
- Progestagenic Agents
- Gestagenic Agents
- Progestin
- Gestagens
- Progestational Agents
Progestin Effect- Progestin Effect
- Effect, Progestin
- Progestogen Effect
- Effect, Progestogen
- Gestagenic Effects
- Effects, Gestagenic
- Gestagen Effect
- Effect, Gestagen
- Gestagen Effects
- Effects, Gestagen
- Gestagenic Effect
- Effect, Gestagenic
- Progestin Effects
- Effects, Progestin
- Progestogen Effects
- Effects, Progestogen
|
Below are MeSH descriptors whose meaning is more general than "Progestins".
Below are MeSH descriptors whose meaning is more specific than "Progestins".
This graph shows the total number of publications written about "Progestins" by people in this website by year, and whether "Progestins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 1 | 3 |
| 2013 | 1 | 1 | 2 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 2 | 3 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Progestins" by people in Profiles.
-
The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome. Br J Cancer. 2007 Apr 10; 96(7):1083-91.
-
Synthetic 19-nortestosterone derivatives as estrogen receptor alpha subtype-selective ligands induce similar receptor conformational changes and steroid receptor coactivator recruitment than natural estrogens. J Steroid Biochem Mol Biol. 2006 May; 99(2-3):108-14.
-
Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids. 2005 May-Jun; 70(5-7):418-26.
-
Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2. Mol Cell Biol. 2004 Dec; 24(24):10542-57.
-
Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer. Gynecol Oncol. 2003 Feb; 88(2):108-17.
-
p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas. Carcinogenesis. 2002 May; 23(5):749-58.
-
Hormone replacement therapy and cancer risk. Curr Opin Oncol. 2001 Sep; 13(5):384-9.
-
A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. Endocrinology. 2001 Sep; 142(9):3791-9.
-
Discovery and characterization of endometrial epithelial messenger ribonucleic acids using the ovine uterine gland knockout model. Endocrinology. 1999 Sep; 140(9):4070-80.
-
Ceramide toxicity and metabolism differ in wild-type and multidrug-resistant cancer cells. Int J Oncol. 1999 Sep; 15(3):535-40.